Observational study on cardiovascular risk factors using non-invasive imaging
Official title: The Oxford Risk Factors And Non-Invasive Imaging Study
Run by University of Oxford · NCT05169333 · Data updated 2026-11-12
This study is trying to see if new imaging techniques can help doctors better understand and predict heart and metabolic diseases in patients getting CT scans.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 250000 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 45 sites (Phoenix, Arizona and 44 other locations) |
| Status | Recruiting |
| Started | February 23, 2016 |
| Main results expected | February 2030 |
| Study ends | February 2030 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT05169333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females aged 18 to 99 who are undergoing CT scans and can provide informed consent.
✕Probably not a fit
Patients with active cancer or those unable to consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Oxford Risk Factors And Non-Invasive Imaging Study (ORFAN) is a prospective, multi-centre observational study aimed at developing and validating novel biomarkers for cardiometabolic diseases. It will collect CT scans, biological samples, and clinical outcomes data from unselected patients undergoing various CT scans at participating centers. By linking imaging data with patient demographics and clinical information, the study seeks to enhance diagnosis and risk prediction through advanced image analysis algorithms. Additionally, it will track disease progression and outcomes through follow-up scans and data collection.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and risk assessment for cardiovascular diseases.
How similar studies have gone: Other studies utilizing similar imaging and biomarker approaches have shown promise, indicating potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion Criteria for study Arms 1, 2 and 3: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 -99 years. Inclusion Criteria for study Arm 4: • Male or Female, aged 18 -99 years. Exclusion Criteria: Exclusion Criteria for Study Arms 1, 2 and 3: * Unable or unwilling to consent * Active cancer Exclusion Criteria for Study Arm 4: * Participation in Study Arms 1, 2 or 3 * Existing opt-out from use of data for research purposes
Where it's running
-
Valleywise Health
Phoenix, Arizona, United States Recruiting -
Yale University, School of Medicine
New Haven, Connecticut, United States Recruiting -
Bridging Medical Silos
Tampa, Florida, United States Recruiting -
Emory University
Atlanta, Georgia, United States Recruiting -
Midwest Heart & Vascular Specialists LLC
Kansas City, Kansas, United States Recruiting -
St Luke's Hospital
Kansas City, Kansas, United States Recruiting
Show 39 more locations
-
NIH National Heart, Lunch, and Blood Institute
Bethesda, Maryland, United States Recruiting -
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting -
Cleveland Clinic
Cleveland, Ohio, United States Recruiting -
UT Southwestern Medical Center
Dallas, Texas, United States Recruiting -
Brooke Army Medical Center (BAMC)
San Antonio, Texas, United States Recruiting -
University of Virginia
Charlottesville, Virginia, United States Recruiting -
Nicosia Polyclinic
Nicosia, Cyprus Recruiting -
GØdstrup Regional hospital
Aarhus, Denmark Recruiting -
Assistance Publique - Hôpitaux de Paris
Paris, France Recruiting -
Friedrich-Alexander-Universitat Erlangen-Nurmberg
Erlangen, Germany Recruiting -
Lefkos Stavros Clinic
Athens, Greece Recruiting -
National and Kapodistrian University of Athens - Hippokration Hospital
Athens, Greece Recruiting -
Semmelweis University
Budapest, Hungary Recruiting -
Centro Cardiologico Monzino IRCCS, University of Milan
Milan, Italy Recruiting -
Isola Tiberina-Gemelli Isola Hospital
Roma, Italy Recruiting -
University of Medicine and Pharmacy of Targu Mures
Târgu Mureş, Romania Recruiting -
Seoul National University
Seoul, South Korea Recruiting -
Taiwan Kaohsiung Medical University
Kaohsiung City, Taiwan Recruiting -
Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom Recruiting -
Sandwell and West Birmingham Hospitals NHS Trust
Birmingham, United Kingdom Recruiting -
Royal Papworth Hospital NHS Trust
Cambridge, United Kingdom Recruiting -
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom Recruiting -
University Hosptials of Leicester NHS Trust
Leicester, United Kingdom Recruiting -
Barts Health NHS Trust
London, United Kingdom Recruiting -
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom Recruiting -
Royal Brompton and Harefield Hospitals
London, United Kingdom Recruiting -
Milton Keynes University Hospital
Milton Keynes, United Kingdom Recruiting -
The Newcastle Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom Recruiting -
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom Recruiting -
Heart and Lung Centre, New Cross Hospital
Wolverhampton, United Kingdom Recruiting -
The University of Sydney
Sydney, Australia Not yet recruiting -
University Hospitals Leuven
Leuven, Belgium Not yet recruiting -
University Hospital Ulm
Ulm, Germany Not yet recruiting -
University Hospitals Birmingham NHS Trust
Birmingham, United Kingdom Not yet recruiting -
University of Edinburgh, Royal Infirmary
Edinburgh, United Kingdom Not yet recruiting -
Golden Jubilee National Hospital
Glasgow, United Kingdom Not yet recruiting -
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom Not yet recruiting -
Liverpool heart and chest hospital
Liverpool, United Kingdom Not yet recruiting -
University Hospital of Manchester NHS Foundation Trust
Manchester, United Kingdom Not yet recruiting
Study contacts
- Principal investigator: Charalambos Antoniades, Prof — University of Oxford
- Study coordinator: Kenneth Chan, Dr
- Email: kenneth.chan@cardiov.ox.ac.uk
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital heart-health app and lifestyle program for adults with heart disease or high-risk diabetes
This program will test whether adding a digital heart-health app and lifestyle support to usual care helps adults on statins with established heart disease or high-risk type 2 diabetes lower their cardiovascular risk.
-
Investigating how sleep and circadian rhythms affect blood pressure in people with hypertension
This study is testing how sleep patterns and daily rhythms affect blood pressure in people with high blood pressure to see if a regular sleep schedule can help.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.